Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) traded down 6% during mid-day trading on Thursday . The company traded as low as $0.47 and last traded at $0.47. 500 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 20,342 shares. The stock had previously closed at $0.50.
Cell MedX Trading Down 6.0 %
The stock has a fifty day simple moving average of $0.33 and a 200 day simple moving average of $0.13.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Recommended Stories
- Five stocks we like better than Cell MedX
- How to Most Effectively Use the MarketBeat Earnings Screener
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Insider Trades May Not Tell You What You Think
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- 3 Stocks to Consider Buying in October
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
